Flat OGTT (Oral Glucose Tolerance Test) During Pregnancy

The Flat OGTT During Pregnancy -Prevalence and Risk for Adverse Outcomes

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04515823

Enrollment

2085

Registered

2020-08-17

Start date

2020-04-26

Completion date

2020-08-01

Last updated

2020-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Related

Brief summary

The aim of the study is to examine the relationship between flat sugar curve on OGTT-glucose tolerance test during pregnancy, neonatal birthweight and other perinatal outcomes.

Detailed description

A retrospective cohort analysis of all women delivered in one university affiliated medical center between January 1st 2018 and December 31th 2019 with documented 100 grams OGTT results.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* Performing the OGTT test during the pregnancy

Exclusion criteria

* lack of documentation or Non-performance of OGTT test during the pregnancy.

Design outcomes

Primary

Measure	Time frame	Description
To evaluate the characteristics and perinatal outcomes of parturients with a flat glucose curve on 100 grams oral glucose tolerance test (OGTT).	10 months	A flat OGTT curve occurs in a younger, leaner population. Although flat OGTT can possibly reflect some degree of hyperinsulinemia, it is generally not associated with adverse maternal or neonatal outcomes.

Countries

Israel

Outcome results